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This article  focuses  on  discoveries  of  the  mechanisms  governing  the  regulation  of glycerolipid  metabolism
and  stress  response  signaling  in  response  to the  phospholipid  precursor,  inositol.  The regulation  of
glycerolipid  lipid metabolism  in  yeast  in  response  to  inositol  is  highly  complex,  but increasingly  well
understood,  and  the  roles  of individual  lipids  in  stress  response  are also increasingly  well  characterized.
Discoveries  that  have  emerged  over several  decades  of genetic,  molecular  and  biochemical  analyses  ofeywords:
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metabolic,  regulatory  and  signaling  responses  of yeast  cells,  both  mutant  and  wild type,  to  the  availability
of  the  phospholipid  precursor,  inositol  are  discussed.
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. Introduction
In the yeast, Saccharomyces cerevisiae,  as in other eukaryotes,
egulation of lipid metabolism is extremely complex, involving
oordination of the biosynthesis and turnover of an enormous
umber of lipid classes and species. All eukaryotic cells share the
hallenge of regulating and coordinating the complex and inter-
onnected pathways of lipid metabolism across multiple, spatially
istinct membrane compartments, adjusting for shifting precursor
vailability and membrane expansion in the course of cell divi-
ion, growth and metabolism. The genes, enzymes and pathways of
ipid metabolism in yeast share substantial homology with those in
igher eukaryotes, including mammals, making yeast an attractive
odel system for biomedical research (Henry et al., 2012).
S. cerevisiae, as a free-living unicellular organism, must con-
inuously monitor and coordinate endogenous metabolic activity
n response to ever changing availability of precursors of lipid
iosynthesis in the growth medium. Indeed, many insights into
undamental mechanisms of genetic regulation of phospholipid
etabolism in yeast have come from studies of the cellular
esponses to the availability of exogenous precursors of phospho-
ipid biosynthesis, especially inositol. The cellular consequences of
nositol depletion have also been studied in mammalian cells and
ompared to yeast in the context of exposure to inositol depleting
rugs lithium and valproic acid (Deranieh and Greenberg, 2009).
arious aspects of regulation and signaling related to lipid and ino-
itol metabolism in yeast have been extensively reviewed (Carman
nd Han, 2011; Carman and Henry, 1999; Chen et al., 2007; Dickson,
008; Gaspar et al., 2007; Greenberg and Lopes, 1996; Henneberry
nd Sturley, 2005; Henry et al., 2012; Jesch and Henry, 2005;
ajerus and York, 2009; Strahl and Thorner, 2007; Tsui and York,
010). Thus it is not the intention of this article to provide a com-
rehensive coverage of the broader topics of lipid and inositol
etabolism in regulation and signaling in eukaryotic cells in gen-
ral. Rather, this article has a primary focus on the discoveries of
echanisms governing the regulation of glycerolipid metabolism
nd the signaling roles of speciﬁc lipids in yeast that have been
ade possible by genetic, molecular and biochemical analyses of
he cellular response to the availability of the phospholipid precur-
or, inositol (Fig. 1).
Inositol serves as an essential precursor in yeast, as in other
ukaryotic cells, for the synthesis of phosphatidylinositol (PI)
Fig. 1), which in turn serves as precursor to many impor-
ant signaling molecules, including phosphoinositides, inositol
olyphosphates (Carman and Han, 2011; Carman and Henry, 1999;
enry et al., 2012; Jesch and Henry, 2005; Majerus and York, 2009;
trahl and Thorner, 2007; Tsui and York, 2010) and inositol con-
aining sphingolipids (Breslow and Weissman, 2010; Deranieh and
reenberg, 2009; Dickson, 2008), as well as glycosylphosphatidyli-
ositol (GPI) anchor proteins (Pittet and Conzelmann, 2007). When
nositol is added to the growth medium of actively proliferating
east cells adapted to growth in its absence, the rate of PI synthesis . . . .  .  . .  . . . . . .  . . . . .  . .  .  . . . . . .  .  . . . . . . .  .  . . .  . . . .  . .  .  .  . . . .  .  .  . . . . .  . . .  .  .  .  . . . .  .  . . . . .  38
and accumulation increases rapidly and dramatically (Gaspar et al.,
2006, 2011; Loewen et al., 2004). Thus, inositol availability has
the potential to inﬂuence many signaling pathways in yeast (Jesch
et al., 2005, 2006). Moreover, inositol availability also inﬂuences
the synthesis of all lipids derived directly or indirectly from phos-
phatidic acid (PA) (Fig. 1), itself a powerful signaling lipid (Carman
and Henry, 2007; Henry et al., 2012).
In wild type cells under conditions of inositol limitation,
hundreds of genes are activated, the most highly regulated of
which is INO1, encoding inositol 3-phosphate synthase (Ino1p), the
enzyme that catalyzes the rate limiting step in the de novo synthe-
sis of inositol (Henry et al., 2012; Jesch et al., 2005, 2006; Santiago
and Mamoun, 2003). However, in addition to genes involved in ino-
sitol and phospholipid biosynthesis, the list of genes activated in
response to inositol limitation also includes many that are known
to be activated by stress response pathways, including the unfolded
protein response (UPR) (Chang et al., 2002, 2004; Cox et al., 1993;
Cox and Walter, 1996; Mori et al., 1992, 1993), the glucose response
pathway (Shirra et al., 2001) and the protein kinase C (PKC) pathway
(Jesch et al., 2010; Nunez et al., 2008).
Thus, the experimental exploitation of yeast mutants defective
in diverse aspects of lipid metabolism and regulation, coupled with
manipulation of the exogenous supply of phospholipid precur-
sors, especially inositol, offers the potential to generate powerful
insights into the diverse regulatory and signaling roles of eukary-
otic lipids. This article will focus on the metabolism, genetics and
molecular biology associated with these discoveries in yeast.
2. Biosynthesis of inositol in S. cerevisiae:  biochemistry,
genetics and regulation
2.1. Isolation and characterization of mutants defective in
inositol biosynthesis and regulation
The rate-limiting step in synthesis of inositol in yeast (Donahue
and Henry, 1981b), as in other eukaryotes, many archaea, and
some hyperthermophilic bacteria (Majumder et al., 1997; Michell,
2007) involves the conversion of d-glucose 6-phosphate to d-
myo inositol-3-phosphate in the cytoplasm by a reaction catalyzed
by the inositol 3-phosphate synthase (IP synthase, Ino1p). Ino-
sitol 3-phosphate is subsequently dephosphorylated by inositol
3-phosphate monophosphatase (Inm1p) (Murray and Greenberg,
1997). However, yeast inm1 mutants are not inositol auxotrophs
and retain considerable inositol 3-phosphate phosphatase activity
(Murray and Greenberg, 2000), suggesting that enzymes in addi-
tion to Inm1p are able to catalyze the dephosphorylation of inositol
3-phosphate. The activity of IP synthase is dramatically reduced
in yeast cells grown in the presence of inositol, indicating that
the enzyme is repressible (Culbertson et al., 1976). The isolation
and characterization of S. cerevisiae mutants unable to grow in the
absence of inositol (Ino– phenotype) permitted the identiﬁcation
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HS,  phytosphingosine. IPs refers to the inositol soluble phosphates (Wilson et al., 2
f the structural gene (INO1), encoding IP synthase (Donahue and
enry, 1981b) and enabled its subsequent cloning (Klig and Henry,
984) and sequencing (Dean-Johnson and Henry, 1989).
Two early screens for S. cerevisiae mutants unable to grow with-
ut inositol supplementation resulted in the isolation of about
50 independently generated inositol auxotrophs (Ino– mutants)
Culbertson and Henry, 1975; Donahue and Henry, 1981a). In com-
arison to wild type, cell extracts from the Ino– mutants were
ound to have little or no IP synthase activity (Culbertson et al.,
976). The mutants fell into genetic complementation groups, cor-
esponding to 20 unlinked genes (Culbertson and Henry, 1975;
onahue and Henry, 1981a). However, only three of these genes
ere represented by more than one mutant allele, with ino1
utants representing about 69% and ino2 and ino4 mutants each
epresenting about 9% of the mutants isolated (Culbertson and
enry, 1975; Donahue and Henry, 1981a). INO1 was  subsequently
hown to be the structural gene encoding the subunit of IP syn-
hase (Ino1p), while INO2 and INO4 were shown to encode positive
egulatory proteins, essential, not only for expression and regula-
ion of IP synthase, but also for regulation of a large number of
o-regulated enzymes of phospholipid biosynthesis (Henry et al.,
012). Recent screenings of yeast genome wide collections of viable
eletion mutants have revealed hundreds of additional individual
iable yeast “gene knock out” mutants that exhibit Ino– pheno-
ypes of varying strength. Many of these mutants are pleiotropic,
xhibiting additional phenotypes on inositol free medium, such
s temperature sensitivity and/or sensitivity to the presence of aL, phospholipids; VLCFA, very-long-chain fatty acids; DHS, dihydrosphingosine;
Ye et al., 2013).
second phospholipid precursor, choline (Villa-Garcia et al., 2011;
Young et al., 2010). These recent ﬁndings indicate that the early
genetic screens for inositol auxotrophy greatly underestimated the
number of loci that are required for sustained growth in the absence
of exogenous inositol under a variety of conditions, a topic to be
discussed later in this review.
Puriﬁcation and biochemical characterization of IP synthase
from extracts of wild type yeast revealed that the enzyme is
a tetramer consisting of four identical subunits (Donahue and
Henry, 1981b), as later conﬁrmed by X-ray crystallography (Geiger
and Jin, 2006; Jin and Geiger, 2003). Immunological analysis of
crude extracts of the original Ino– mutants conducted with anti-
body raised in response to puriﬁed IP synthase subunit (Ino1p)
revealed that many ino1 mutants retained Ino1p cross-reacting
material, consistent with their identiﬁcation as structural gene
mutants expressing an inactive mutant subunit (Donahue and
Henry, 1981b). In contrast, Ino1p cross-reacting material was com-
pletely absent or greatly reduced in Ino– mutants representing the
other loci, suggesting that their defects were most likely regulatory
in nature (Donahue and Henry, 1981b). Based on these ﬁndings,
the INO1 gene was identiﬁed as the structural gene encoding the
subunit of IP synthase, the ﬁrst IP synthase structural gene to be
identiﬁed in any organism (Donahue and Henry, 1981b). Ino1p was
also shown to be largely absent from extracts of wild type yeast cells
grown in the presence of inositol, conﬁrming that the enzyme is
repressed at the level of expression of the protein subunit (Donahue
and Henry, 1981b). Subsequent analysis of IP synthase enzymes
26 S.A. Henry et al. / Chemistry and Phys
Fig. 2. Overproduction of inositol (Opi–) phenotype of opi1 strain. Wild type (wt)
and  opi1 cells were spotted on plates containing I– medium and incubated for
2  days at 30 ◦C. A cell suspension of AID indicator strain, which grows only in the
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Iresence of inositol, was  sprayed on the plates and incubated for a further 2 days
t  30 ◦C. Strains excreting inositol are visible as red halos around the strain being
ested.
nd genes from a wide variety of organisms has revealed a high
egree of sequence conservation, particularly among eukaryotes
Majumder et al., 2003). Signiﬁcantly, IP synthase is a phosphopro-
ein in both yeast and humans (Deranieh et al., 2013) and the human
P synthase gene (hINO1) is able to rescue the inositol auxotrophy
f the ino1 mutant when expressed in yeast (Ju et al., 2004). Anal-
sis of phosphorylation defective and phosphomimetic mutations
nvolving three phosphorylation sites, which are conserved in yeast
nd human IP synthases, suggests that that the serine residues at
wo of these sites play critical roles, given that phosphorylation
t each of these sites inhibits enzyme activity in both yeast and
umans (Deranieh et al., 2013).
Yeast mutants defective in repression of Ino1p in response to
nositol were ﬁrst identiﬁed on the basis of a phenotype known as
pi–, overproduction and excretion of inositol (Greenberg et al.,
982b). The plate assay used in the original screen for mutants
ossessing this phenotype involved allowing mutagenized cells to
row into colonies on medium lacking inositol and then spray-
ng the plates with a suspension of an inositol auxotrophic diploid
train (AID), which also carried a mutation in adenine biosynthe-
is (MATa/MAT, ade1/ade1,  ino1-13/ino1-13, lys2/LYS2). Inositol
xcreting (Opi–) mutants were identiﬁed by the growth of the indi-
ator strain in a red halo around inositol excreting colonies (Fig. 2)
Greenberg et al., 1982b; Swede et al., 1992). The opi1-1 mutant
solated in the initial screening for mutants with the Opi– pheno-
ype (Greenberg et al., 1982b), exhibited about twofold higher IP
ynthase activity and Ino1p subunit levels than in wild type cells
rown under derepressing conditions (i.e. in the absence of ino-
itol). The opi1-1 mutant also failed to repress IP synthase when
rown in the presence of inositol. On this basis Opi1p was iden-
iﬁed as a repressor of IP synthase expression (Greenberg et al.,
982a).
.2. In yeast, enzymes of phospholipid biosynthesis are
oordinately regulated in response to inositol and choline
An early indication that many enzymes of phospholipid biosyn-
hesis in yeast are regulated coordinately with IP synthase in
esponse to inositol emerged from the discovery that ino2 and ino4
utants are pleiotropic. In addition to being unable to express
P synthase (Donahue and Henry, 1981a), ino2 and ino4 mutantsics of Lipids 180 (2014) 23–43
exhibit reduced capacity to convert phosphatidylethanolamine
(PE) to phosphatidylcholine (PC) (Fig. 1) (Loewy and Henry,
1984). The opi1-1 mutant also proved to be pleiotropic, exhibiting
constitutive expression, not only of IP synthase, but also phospha-
tidylserine (PS) synthase and the phospholipid methyltransferases
that convert PE to PC (Fig. 1) (Klig et al., 1985). In wild type
cells, these same enzymes were shown to exhibit a unique pat-
tern of coordinate regulation in response to inositol and choline.
Full expression of these coordinately regulated enzymes of phos-
pholipid biosynthesis is observed in wild type cells grown in the
absence of inositol, whether choline is present or not. When ino-
sitol is present in the growth medium, the co-regulated enzymes
are repressed and a further level of repression occurs when choline
is present along with inositol. However, choline in the absence of
inositol has little or no effect (Klig et al., 1985).
In related observations, Yamashita and Oshima (1980) reported
a yeast mutant auxotrophic for choline, which exhibited low phos-
pholipid methyltransferase activity in the presence of inositol.
These investigators also observed that phospholipid methyltrans-
ferase activity was  reduced in some wild type strains grown in
the presence of inositol. Other early studies on the regulation of
synthesis of PC via methylation of PE (Fig. 1) were conducted
with yeast grown in synthetic complete medium containing yeast
nitrogen base (YNB), which contains a low level of inositol (about
10 M).  The concentration of inositol found in YNB medium was
later found to cause partial repression of phospholipid biosyn-
thetic genes (Hirsch and Henry, 1986). In early studies conducted in
YNB media, the repression of PC biosynthesis was  understandably
attributed solely to the effect of additional phospholipid precur-
sors, such as choline (Carson et al., 1982, 1984; Waechter and Lester,
1971, 1973). However, the presence of exogenous choline was sub-
sequently shown to have little or no effect on the expression of INO1
and coregulated genes of phospholipid biosynthesis when inositol
is absent from the medium (Hirsch and Henry, 1986; Jesch et al.,
2005). Other enzymes catalyzing reactions involved in biosynthesis
of PC via the pathway from CDP-diacylglycerol (CDP-DAG) (Fig. 1)
are also repressed in a similar fashion in response to exogenous
inositol in combination with choline or other phospholipid precur-
sors, such as serine or ethanolamine (Homann et al., 1985, 1987;
Klig et al., 1985, 1988a; Lamping et al., 1991; Poole et al., 1986).
2.3. Structural genes encoding enzymes of phospholipid
biosynthesis are subject to complex transcriptional regulation
The isolation of the yeast INO1 gene, proved to be key to under-
standing the complex cellular transcriptional response to inositol
(Henry et al., 2012). The presence of 75 M inositol in the growth
medium was  initially shown by slot blot analysis to repress INO1
transcription in wild type cells by more than 10-fold (Hirsch and
Henry, 1986). However, 10 M inositol, a concentration similar to
that found in standard yeast nitrogen base (YNB) medium, was
shown to permit partial de-repression of INO1 during active growth
(Hirsch and Henry, 1986). Under inositol limiting conditions, dere-
pression of INO1 occurs when exogenous inositol is depleted, and as
growth progresses, wild type yeast derepress INO1 and must rely
on endogenous synthesis of inositol catalyzed by Ino1p to reach
stationary phase. When exogenous inositol is completely absent
or has been completely depleted during active growth, wild type
yeast cells grow at a somewhat reduced rate in comparison to cells
fully supplemented with inositol (Gaspar et al., 2011). Consistent
with these observations, Hanscho et al. (2012) recently reported
that wild type yeast growing in YNB media, in the absence of any
additional inositol supplementation, are unable to maintain rapid
cell proliferation until the glucose in the medium is fully depleted.
Recent studies using more sensitive RT-PCR methods, have shown
that expression of the INO1 gene increases by 200–300 hundred
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old within the ﬁrst two  to three hours following an abrupt shift of
ctively dividing cells from medium containing a fully repressing
evel of inositol (75–100 M)  to medium lacking inositol. However,
s cells acclimate to long-term growth in the absence of inosi-
ol, INO1 expression attenuates to a level of approximately 100-
o 150-fold over fully repressed levels, depending on the precise
rowth conditions employed (Gaspar et al., 2011). In contrast to
he several hours required for full derepression of INO1 following
emoval of inositol, almost complete repression is achieved within
bout 30 min  following addition of inositol to cultures of wild type
ells that have been fully acclimated to growth in its absence (Jesch
t al., 2006). When a fully repressing concentration of inositol is
resent, the presence of choline (Fig. 1) results in a further sev-
ral fold reduction in INO1 expression. However, as stated above,
xogenous choline has little or no effect on INO1 expression when
nositol is absent from the medium (Gaspar et al., 2011; Hirsch and
enry, 1986; Jesch et al., 2005).
Furthermore, even in the absence of inositol, INO1 and coregu-
ated genes and enzymes are repressed as cells enter stationary
hase (Homann et al., 1987; Lamping et al., 1994). However, in
pi1 cells, INO1 expression continues at high, derepressed levels
nto stationary phase, both in the presence and absence of ino-
itol (Griac et al., 1996; Jiranek et al., 1998). The INO1 gene was
lso shown to be transiently repressed when wild type cells, loga-
ithmically growing in the absence of inositol in standard medium
ontaining ammonium sulfate as a nitrogen source, were shifted
o inositol-free medium containing a mixture of amino acids and
ases as nitrogen sources. This result indicates that INO1 expres-
ion is sensitive to nitrogen limitation during active growth in the
bsence of inositol. In contrast, opi1 cells continued to express
NO1 at high constitutive levels, without interruption, when shifted
nder identical conditions to medium lacking both ammonium sul-
ate and inositol, indicating that Opi1p is necessary for repression
n response to nitrogen limitation, as well as in response to inositol
Griac and Henry, 1999).
Cloning of the CHO1 gene (Letts et al., 1983), encoding PS
ynthase (Atkinson et al., 1980a,b; Kovac et al., 1980) and the
HO2 (PEM1) and OPI3 (PEM2) genes, encoding the two yeast
hospholipid methyltransferases responsible for methylation of
E to form PC (Kodaki and Yamashita, 1987; Summers et al., 1988)
Fig. 1), permitted comparison of their transcriptional regulation
o that of INO1. As in the case of INO1 (Hirsch and Henry, 1986),
xpression of CHO1, CHO2 and OPI3 is repressed when inositol
s present in the growth medium and is further repressed when
holine is also present (Bailis et al., 1987, 1992; Gaynor et al.,
991; Hosaka and Kodaki, 1990; Kanipes and Henry, 1997; Kodaki
t al., 1991b; Kodaki and Yamashita, 1987, 1989; Nikawa et al.,
987a; Summers et al., 1988). Many other genes related to lipid
etabolism have subsequently been shown to show a similar pat-
ern of regulation. For example, synthesis of S-adenosyl methionine
SAM), the methyl donor in conversion of PE to PC (Bremer and
reenberg, 1959; Gibson et al., 1961) is catalyzed by S-adenosyl
ethionine synthase. S. cerevisiae has two S-adenosyl methionine
ynthase genes, SAM1 and SAM2 (Thomas et al., 1988; Thomas
nd Surdin-Kerjan, 1987) and the SAM2 gene is regulated by
nositol and choline, whereas SAM1 is not (Kodaki et al., 2003). The
AH1 gene, encoding S-adenosyl-l-homocysteine hydrolase is also
epressed in a similar fashion in response to inositol and choline
Tehlivets et al., 2004). Moreover, down regulation of expression
f SAH1 leads to decreased PC levels, increased accumulation of
riacylglycerol levels and derepression of INO1 (Malanovic et al.,
008). Many additional genes encoding enzymes involved in
hospholipid biosynthesis have been shown to exhibit a similar
attern of transcriptional regulation in response to inositol and
holine. These co-regulated genes include: PSD1, encoding the
itochondrial PS decarboxylase, but not PSD2, encoding the ERics of Lipids 180 (2014) 23–43 27
localized PS decarboxylase (Griac, 1997; Lamping et al., 1991)
and CDS1, encoding CDP-DAG synthase and PGS1, encoding phos-
phatidylglycerolphosphate synthase (Shen and Dowhan, 1998). A
number of genes in the Kennedy pathway for PC and PE biosynthe-
sis (Fig. 1), including CKI1, encoding choline kinase, PCT1, encoding
cholinephosphotransferase, EPT1, encoding ethanolaminephos-
photransferase and EKI1, encoding ethanolamine kinase, are also
regulated in a similar fashion (Hosaka et al., 1990; Kim et al., 1999;
McMaster and Bell, 1994b). The genes encoding the high and
low afﬁnity transporters of inositol, ITR1 and ITR2, also show this
pattern of regulation (Lai and McGraw, 1994), as does the choline
transporter HNM1/CTR1 (Li et al., 1991; Nikawa et al., 1986).
Several genes involved in fatty acid synthesis, FAS1, FAS2, encoding
the  and , and ACC1/FAS3 encoding acetyl-CoA carboxylase, also
exhibit repression in response to inositol and choline (Chirala,
1992; Chirala et al., 1987, 1994; Hasslacher et al., 1993; Schuller
et al., 1992a,b; Schwank et al., 1995).
However, not all genes involved in phospholipid metabolism
in yeast are repressed in response to inositol. In contrast to INO1,
the INM1 gene, encoding inositol 3-phosphate phosphatase and
the DPP1 and PAH1 genes, encoding lipid phosphate phosphatases,
are derepressed in the presence of inositol and in stationary phase
(Murray and Greenberg, 1997, 2000; Oshiro et al., 2000; Pascual
et al., 2013). Regulation of the PIS1 gene, encoding phosphatidyl-
inositol synthase (Nikawa et al., 1987a) is largely uncoupled from
regulation by inositol and choline but requires Ino4p for full expres-
sion and is induced about twofold by inositol, a response requiring
the pleiotropic regulatory protein Ume6p (Jani and Lopes, 2008).
Importantly, altered expression of PIS1 has profound effects on the
expression of INO1 and coregulated genes and on levels of PI, PA and
PC (Gardocki et al., 2005; Jani and Lopes, 2009), as will be discussed
below. Some genes encoding phospholipid biosynthetic enzymes,
including PIS1, PAH1, CKI1 and EKI1, are also regulated by zinc in the
absence of inositol. The regulation of these genes by zinc involves
control of the level of PA by activation of PI synthase in the absence
of inositol via the Zap1 transcription factor (Carman and Han, 2007;
Henry et al., 2012).
A number of previous reviews (Carman and Han, 2011; Carman
and Henry, 1999; Greenberg and Lopes, 1996; Henry et al., 2012;
Paltauf et al., 1992) provide excellent and detailed coverage of
the genes and enzymes subject to regulation by inositol and
choline. Microarray analysis has also revealed many additional
genes, genome wide, that are regulated in response to inositol and
choline (Jesch et al., 2005, 2006; Santiago and Mamoun, 2003).
However, many of the genes identiﬁed as being activated in genome
wide microarray studies of wild type cells growing in the absence
of inositol are not involved in lipid metabolism and are not reg-
ulated in coordination with INO1 and coregulated genes of lipid
metabolism. Rather, they are targets of stress response pathways
that are activated when wild type cells are grown in the absence of
inositol (Henry et al., 2012; Jesch et al., 2005, 2006, 2010; Lee et al.,
2013; Nunez et al., 2008); a topic discussed below.
2.4. Regulation of INO1 and co-regulated genes involves the
interaction of the Ino2p and Ino4p transcription factors, with each
other, and with the UASINO promoter element and the Opi1p
repressor
As described above, unlike wild type, ino2 and ino4 mutants
fail to derepress INO1 when shifted to medium containing a con-
centration of inositol of 10 M inositol or less, leading to the
identiﬁcation of Ino2p and Ino4p as positive regulators of INO1 tran-
scription (Hirsch and Henry, 1986). The INO2 and INO4 genes were
cloned, sequenced and shown to encode proteins each containing
a Helix-Loop-Helix (HLH) motif (Hoshizaki et al., 1990; Klig et al.,
1988b; Nikoloff and Henry, 1994; Nikoloff et al., 1992; Schwank
et al., 1995). The HLH motif is found in many eukaryotic regulatory
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roteins, including mammalian Myc  and Max  (Amati and Land,
994), as well as a number of other yeast regulatory proteins
Robinson and Lopes, 2000). Ino2p and Ino4p were shown to bind as
 heterodimer (Ambroziak and Henry, 1994; Schwank et al., 1995)
o a repeated element, UASINO. UASINO is found in multiple copies in
he promoter of the INO1 gene and in the promoters of other genes
hat are regulated in coordination with INO1 in response to inosi-
ol and choline (Bachhawat et al., 1995; Bailis et al., 1992; Lopes
nd Henry, 1991; Lopes et al., 1991). The genes shown to contain
unctional copies of this element include CHO1/PSS,  encoding PS
ynthase (Bailis et al., 1987, 1992; Kodaki et al., 1991b; Nikawa
t al., 1987b) and the OPI3/PEM2 and CHO2/PEM1 genes, encoding
he phospholipid methyltransferases required for conversion of PE
o PC (Kodaki et al., 1991a; Koipally et al., 1996; Summers et al.,
988) (Fig. 1). The FAS1, FAS2 and ACC1/FAS3 genes involved in fatty
cid biosynthesis, also contain functional copies of UASINO, alter-
ately referred to as ICRE (inositol choline responsive element)
Schuller et al., 1992a, 1992b; Schwank et al., 1995). The UASINO
lement, consensus sequence 5′CATGTGAAAT3′ (Bachhawat et al.,
995), has subsequently been found in the promoters of many other
east genes (Carman and Han, 2011; Carman and Henry, 1999; Chen
t al., 2007; Greenberg and Lopes, 1996; Henry et al., 2012; Kellis
t al., 2003).
The INO1 gene, which carries multiple copies of UASINO, exhibits
 higher repression/derepression ratio in response to inositol alone,
r inositol plus choline, than any other UASINO containing gene
Jesch et al., 2005, 2006; Santiago and Mamoun, 2003). The higher
epression ratio of INO1 in comparison to other UASINO contain-
ng genes is in part attributable to the fact that its promoter
lso contains a copy of an upstream repression sequence, URS1,
′AGCCGCCCA3′ (Lopes et al., 1993), found in a number of other
enes in yeast not related to lipid metabolism. Reporter gene con-
tructs derived from the native INO1 promoter lacking the URS
lement show increased expression under both repressing (pres-
nce of inositol and choline) and derepressing (absence of inositol
nd choline) conditions (Lopes et al., 1993). Mutations in the SIN3
ene also render the cell unable to fully repress the INO1, CHO1,
HO2 and OPI3 genes (Fig. 1) in the presence of inositol or ino-
itol and choline, indicating that Sin3p plays a role in the full
epression of these UASINO containing genes (Hudak et al., 1994).
in3p reduces expression of INO1 by interaction, both with the
RS1 element and with UASINO. Sin3p is a co-repressor and com-
onent of a negative regulatory complex, which also contains
he Rpd3p histone deacetylase and Ume6p (Kadosh and Struhl,
997, 1998; Kurdistani et al., 2002). While Ume6p negatively regu-
ates INO1 through the URS1 element, it positively regulates CHO1,
HO2, and OPI3 (Jackson and Lopes, 1996) through an indirect
ffect on INO2 expression (Elkhaimi et al., 2000). Ume6p, as men-
ioned above, is also a positive regulator of PIS1 (Jani and Lopes,
008). The Opi1p repressor interacts with Ino2p, as well as the
leiotropic co-repressors, Sin3p and Ssn6p, at UASINO elements
Jaschke et al., 2011). These interactions result in recruitment of
ultiple histone deacetylases, including Rpd3p, Hda1p and Hos3p,
hich are collectively necessary for Opi1p mediated repression of
ASINO containing genes by inositol and choline (Grigat et al., 2012).
nterestingly, global histone acetylation is regulated by acetyl CoA
arboxylase, encoded by the ACC1 gene (Galdieri and Vancura,
012), which as described above contains UASINO element in its
romoter. Galdieri and Vancura (2012) reported that attenuated
xpression of ACC1 results in increased bulk histone acetylation
nd altered transcriptional regulation, including increased INO1
xpression. These results are consistent with the previous report
y Shirra et al. (2001), which showed that reduced activity of Acc1p
esulted in increased expression of INO1. Thus, histone acetyla-
ion/deacetylation is, itself, regulated by the rate-limiting step in
atty acid biosynthesis.ics of Lipids 180 (2014) 23–43
However, full derepression of the INO1 gene also requires coop-
eration between the Ino2p/Ino4p heterodimer and a third HLH
protein, Cbf1p (centromere binding factor 1), through a region
distal to the INO1 promoter that encompasses an upstream open
reading frame, SNA1. Binding of Cbf1 to upstream sites is required
for binding of the ISW2 chromatin-remodeling complex, which is
also required for full INO1 derepression (Shetty and Lopes, 2010).
Cbf1p also interacts with Met4p, a transcriptional activator in
the sulfur assimilation pathway, which is required for activation
of genes, including SAM1 and SAM2,  described above, which are
required for maintaining levels of S-adenosyl methionine (SAM)
(Hickman et al., 2011; Petti et al., 2012), the methyl donor in the
phospholipid methylation reactions catalyzed by Cho2p and Opi3p
in the synthesis of PC from PE (Fig. 1). Whereas Met4p is required
for SAM2 activation, Opi1p is a direct repressor of SAM2 (Hickman
et al., 2011).
The fact that the INO2 and INO4 genes also contain UASINO
like elements in their own  promoters and are subject to auto-
regulation (Ashburner and Lopes, 1995a) introduces a further
level of complexity in the regulation of INO1 and other UASINO
containing genes. Thus, INO2 requires both Ino2p and Ino4p for
expression and is regulated by inositol and choline. In contrast,
INO4 is auto-regulated, requiring only Ino4p for its expression, and
is constitutively expressed in the presence of inositol and choline
(Ashburner and Lopes, 1995a). A further study, in which the INO2
gene was placed under the control of the GAL1 promoter, revealed
that cells containing the GAL1 driven INO2 construct could still
regulate expression of both INO1 and CHO1 in response to inosi-
tol. However, the level of expression of these two  structural genes
under the control of the GAL1 promoter was correlated, both in
the absence and in the presence of inositol, to the relative level of
expression of the INO2 gene. However, deletion of the OPI1 gene
in a strain carrying INO2 under the control of GAL1 driven INO2
construct led to constitutive expression of INO1 in the presence of
inositol (Ashburner and Lopes, 1995b). These results indicate that
Opi1p, rather than Ino2p, is the sensor for the regulatory signal that
is generated in the presence of inositol and is responsible for repres-
sion of UASINO containing genes. This insight was later validated,
as will be discussed below, when Opi1p was found to interact in
the endoplasmic reticulum (ER) with the phospholipid precursor,
phosphatidic acid (PA), which is highly elevated in cells grown in
the absence of inositol (Loewen et al., 2004). However, a low resid-
ual level of expression and regulation of INO1 in response to inositol
and choline was observed in strains carrying various combinations
of deletions of the OPI1, INO2, INO4 and SIN3 genes, namely: opi1
ino4, opi1 ino2 ino4,  sin3 ino2 ino4 and opi1 sin3
ino2 ino4 (Graves and Henry, 2000), suggesting that the full
complexity of this regulation has yet to be completely described.
As described above, the INO1 gene shows a much higher repres-
sion/derepression ratio in response to availability of inositol than
any other gene in the yeast genome, including all other UASINO
containing genes such as OPI3 and CHO1 (Jesch et al., 2005, 2006;
Santiago and Mamoun, 2003). Inositol auxotrophy (Ino– pheno-
type) (Villa-Garcia et al., 2011; Young et al., 2010), and/or reduced
INO1 transcription, has been observed in many other mutants,
including mutants defective in components of RNA polymerase II
(Berroteran et al., 1994; Hampsey, 1997; Nonet and Young, 1989;
Scafe et al., 1990), the RNA polymerase II SRB/mediator com-
plex and the Paf1 and CCR4-NOT complexes (Betz et al., 2002;
Koleske et al., 1992). Mutants defective in components of many
other complexes involved in transcriptional regulation, including
SWI/SNF (Peterson and Herskowitz, 1992), Ino80 (Ebbert et al.,
1999; Fernandez-Murray et al., 2009; Shen et al., 2003a), ADA and
SAGA complexes (Gansheroff et al., 1995; Horiuchi et al., 1997;
Roberts and Winston, 1996) and subunits of the Set3p deacetylase
complex (Cohen et al., 2008) exhibit Ino– phenotypes. In addition,
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utants defective in several steps in the production of the inositol
olyphosphates (Fig. 1), also exhibit Ino– phenotypes (Villa-Garcia
t al., 2011; Ye et al., 2013). This phenotype is likely due to misregu-
ation of INO1 transcription (Shen et al., 2003b; Steger et al., 2003;
e et al., 2013). Inositol polyphosphates regulate transcription by
ontrolling the activity of chromatin remodeling complexes. Other
uclear functions of inositol polyphosphates also include regula-
ion of mRNA export as well as telomere maintenance (York, 2006).
o date, eight distinct inositol polyphosphates have been detected
n yeast (Wilson et al., 2013), which are produced by the phos-
holipase C mediated turnover of PI(4,5)P2, and the subsequent
hosphorylation of IP3 (Fig. 1). Overall, these phenotypes suggest
hat transcription of the INO1 gene is more sensitive to pertur-
ations in the cellular transcription apparatus than other UASINO
ontaining genes. In addition, screening of genome wide collec-
ions of viable deletion mutants for the Ino– phenotype has revealed
any additional mutants with the Ino– phenotype, which are not
irectly involved in lipid metabolism or in RNA II polymerase medi-
ted transcription. Many of these additional mutants have defects
n various stress response pathways or in membrane trafﬁcking
Villa-Garcia et al., 2011; Young et al., 2010), topics discussed in
he ﬁnal sections of this review.
. Mutations in structural genes encoding a number of
nzymes involved in phospholipid biosynthesis affect
egulation of INO1
Yeast does not synthesize choline de novo, but rather in the
bsence of exogenous choline, relies on synthesis of PC via the
DP-DAG pathway, starting with the synthesis of PA and passing
hrough the intermediates CDP-DAG, PS and PE (Fig. 1) (McMaster
nd Bell, 1994a). Surprisingly, strains carrying mutations in struc-
ural genes encoding enzymes involved in biosynthesis of PC via
he CDP-DAG pathway also exhibit phenotypes indicative of mis-
egulation of INO1. These regulatory phenotypes are not seen in
utants defective in the Kennedy pathway for PC biosynthesis via
iacylglycerol (DAG) (Fig. 1) for PC biosynthesis (Henry et al., 2012;
enry and Patton-Vogt, 1998). Speciﬁcally, mutants defective in
he CDP-DAG pathway exhibit regulatory phenotypes including
levated expression of INO1, even in the presence of inositol, as
ell as the Opi– phenotype in the absence of inositol. In cho1, cho2
nd opi3 mutants, these regulatory phenotypes are “conditional”.
n these mutants, constitutive overexpression of INO1 and coregu-
ated genes is eliminated when the mutant in question is provided
ith a soluble precursor of PC that can enter the Kennedy path-
ay, bypassing the mutated step in the CDP-DAG pathway, thus
estoring PC synthesis. The conditional regulatory phenotypes in
hese mutants led to the hypothesis that a signal necessary for
epression/derepression of INO1 and co-regulated genes is gener-
ted in the course of active phospholipid biosynthesis (Henry and
atton-Vogt, 1998). As described below, these insights, ultimately
nd collectively, led to the discovery that build up of PA, precursor
o all phospholipids, as well as DAG and TAG (Fig. 1), is the metabolic
ignal responsible for derepression of the UASINO containing genes
Henry et al., 2012; Henry and Patton-Vogt, 1998; Loewen et al.,
004).
.1. Some mutations in structural genes encoding enzymes of PC
iosynthesis exhibit misregulation of INO1
The ﬁrst structural gene mutant defective in PC biosynthesis to
e identiﬁed as having altered regulation of Ino1p was the opi3
utant, which was isolated on the basis of its Opi– phenotype in the
ame genetic screen as the original opi1-1 mutant (Greenberg et al.,
982b). The opi3 mutant was subsequently shown to be defective inics of Lipids 180 (2014) 23–43 29
synthesis of PC via PE methylation (Fig. 1) (Greenberg et al., 1983).
The original opi3 mutant synthesized only 2–3% of the level of PC
found in wild type cells and yet did not require choline supplemen-
tation for growth. The opi3 mutant (McGraw and Henry, 1989),
similar to the original opi3 mutant isolated by Greenberg et al.
(1983), also does not require choline for growth. When grown in the
absence of inositol and choline, opi3 mutants accumulate high lev-
els of the intermediates phosphatidylmonomethylethanolamine
(PMME) and phosphatidyldimethylethanolamine (PDME) (Fig. 1).
In comparison, wild type strains produce only trace amounts of
these compounds (Greenberg et al., 1983). The OPI3 gene (also
known as PEM2) was shown to encode the phospholipid methyl-
transferase that is primarily responsible for catalyzing the ﬁnal two
methylations in the conversion of PE to PC (i.e. the conversion of
PMME  to PDME and PDME to PC, Fig. 1) (Kodaki and Yamashita,
1987, 1989; McGraw and Henry, 1989; Summers et al., 1988). How-
ever, the presence of choline in the growth medium restores of PC
biosynthesis in opi3 mutants by the Kennedy pathway (Fig. 1), and
simultaneously eliminates the Opi– phenotype and restores repres-
sion of INO1 in response to inositol (Greenberg et al., 1983; McGraw
and Henry, 1989). The cho2 (pem1) mutant, defective in the
methyltransferase, which is primarily responsible for the ﬁrst of the
three methylations required for the synthesis of PC from PE (Fig. 1),
exhibits similar conditional regulatory phenotypes (Summers et al.,
1988). Similar to opi3,  the cho2 mutant has an Opi–phenotype
and exhibits constitutive expression of INO1. However, in the case
of cho2 mutant, these regulatory phenotypes are eliminated not
just by the presence of exogenous choline, but also by MME  and
DME, precursors that can enter the Kennedy pathway, bypassing
the block in PE methylation, thus restoring PC synthesis (Fig. 1)
(Summers et al., 1988).
The cho1 mutants, defective in PS synthase (Fig. 1), cannot
synthesize PS under any growth condition. Despite being unable
to synthesize PS under any growth condition, cho1 mutants,
including cho1,  are able to grow if provided with ethanolamine
or choline (ethanolamine/choline auxotrophy) (Atkinson et al.,
1980a,b; Kovac et al., 1980). However, cho1 mutants express
Ino1p even in the presence of inositol when shifted to medium
lacking both ethanolamine and choline. cho1 mutants also over-
produce and excrete inositol (Opi– phenotype) when shifted
to medium lacking ethanolamine and choline as well as ino-
sitol (Letts and Henry, 1985). cho1, cho2 and opi3 mutants all
accumulate metabolic precursors below the speciﬁc metabolic
“bottleneck” resulting from their individual mutations in the CDP-
DAG pathway leading through PS and PE to PC (Fig. 1). Moreover,
down-regulation of expression of SAH1, encoding S-adenosyl-l-
homocysteine hydrolase, which is necessary for the degradation
of S-adenosyl-l-homocysteine, a potent inhibitor of adenosyl-
methionine dependant methyltransferases, including Cho2p and
Opi3p, leads to decreased PC synthesis and also results in dere-
pression of INO1 (Malanovic et al., 2008). In the cho1, cho2 and
opi3 mutants, the provision of an exogenous precursor that enters
the Kennedy pathway above the mutational block speciﬁc to each
mutant enables PC biosynthesis via the Kennedy pathway. In each
case, the restoration of PC biosynthesis simultaneously eliminates
the Opi– phenotype and restores INO1 repression in response to
inositol. Thus, ethanolamine and choline restore INO1 regulation
and PC synthesis in cho1 mutants, while MME,  DME or choline suf-
ﬁce in cho2 mutants, but only choline can restore INO1 regulation in
response to inositol in opi3 mutants (Henry and Patton-Vogt, 1998).
3.2. Effects on INO1 regulation of combinations of mutations in
the Kennedy and CDP-DAG pathways for PC biosynthesis
In wild type cells, however, exogenous choline inﬂuences INO1
regulation only if inositol is also present (Hirsch and Henry, 1986)
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nd mutations in the Kennedy pathway, including and pct1 have
ittle effect by themselves on INO1 regulation (Griac et al., 1996). In
 cho2 pct1 ept1 strain, however, INO1 expression is imper-
ious to repression by every combination of inositol, choline and
thanolamine supplementation, indicating that an active Kennedy
athway is required for restoration of regulation by inositol in the
ho2 mutant (Griac et al., 1996). The EPT1 and PCT1 (originally
amed CPT1) are also UASINO containing genes and are regulated in
esponse to inositol and choline following the same general pattern
s INO1. Morash et al. (1994) studied the inﬂuence of the Kennedy
athway on various aspects of phospholipid metabolism and reg-
lation in response to exogenous inositol and choline in pct1,
pt1 and pct1ept1 strains. They showed that pct1 strains
o not repress EPT1 in response to inositol and choline, whereas
he ept1 mutation has no effect on regulation of PCT1. McMaster
nd Bell (1994b) used a variety of constructs and strains to dissect
he inﬂuence of Ept1p and Cpt1p on both choline uptake and regu-
ation of PC biosynthesis in response to inositol. They observed that
he rate incorporated at which labeled serine was into PC at which
abeled serine was reduced in wild type, pct1 and ept1 strains
hen inositol was present. Serine enters the phospholipid biosyn-
hesis via the reaction catalyzed by PS synthase (Cho1p, Fig. 1).
owever, the pct1 strain showed reduced incorporation of 32P
nto PC in both wild type and ept1 strains in the presence of
nositol, despite showing no change in the rate of incorporation of
abeled serine into PC under these same conditions. McMaster and
ell (1994b) concluded that this result could only be explained by
urnover of PC produced via the CDP-DAG pathway, thereby releas-
ng free choline, which is reincorporated into PC via the Kennedy
athway (Fig. 1) in both wild type and ept1 strains. However,
eincorporation of choline produced by PC turnover is blocked in
he pct1 mutant (Fig. 1), thus explaining the reduced 32P incor-
oration into PC in this mutant. Indeed, these results reported by
cMaster and Bell (1994b) foreshadowed the subsequent obser-
ation by Patton-Vogt et al. (1997) that mutants in the Kennedy
athway, which are unable to reincorporate free choline produced
ia PC turnover, excrete it into the medium.
Using combinations of mutants defective in the CDP-DAG and
ennedy pathways for PC biosynthesis, Griac et al. (1996) showed
hat the ability of such mutants to repress INO1, and by inference
ll other UASINO containing genes, is not speciﬁc to the route by
hich synthesis of PC occurs (i.e. via the Kennedy versus CDP-DAG
athways, Fig. 1). Nor is any single intermediate in the Kennedy
athway or in the pathway from CDP-DAG to PC responsible for
he regulatory signal that controls repression/derepression of these
enes in response to inositol. Rather, the evidence suggested that
he overall ability of the cell to synthesize PC somehow created
 signal necessary for the cell to be able to sense inositol (Griac
t al., 1996). This hypothesis, however, proved to be only partially
orrect. In mutants blocked in PC synthesis via CDP-DAG, the sig-
al for repression of INO1 is not PC synthesis itself, but rather the
uild up of PA, the immediate precursor of CDP-DAG (Fig. 1). As dis-
ussed below, under certain growth conditions, mutations in any
f the steps from PA to PC via CDP-DAG can produce metabolic bot-
lenecks that result in the accumulation of PA. PA accumulation is
he signal responsible for derepression of INO1 and other UASINO
ontaining genes in the absence of inositol, as well as the consti-
utive over-expression these genes and the Opi– phenotype in the
utants defective in the CDP-DAG pathway (Henry et al., 2012;
enry and Patton-Vogt, 1998; Loewen et al., 2004; Sreenivas et al.,
998).
While the cho2 and opi3 mutations slow metabolism fromE to PC, exhibit decreased PC synthesis and misregulation of
NO1, resulting in the Opi–phenotype (Griac et al., 1996; Kodaki
nd Yamashita, 1987, 1989; McGraw and Henry, 1989; Summers
t al., 1988), these mutants, unlike cho1 mutants, are not cholineics of Lipids 180 (2014) 23–43
auxotrophs. The lack of choline auxotrophy in cho2 and opi3
mutants is presumably due, both to the overlapping sub-
strate speciﬁcities of the phospholipid methyltransferase enzymes
encoded by the OPI3 and CHO2 genes and the ability of PDME,
but not PMME,  to substitute for PC to some degree in membrane
biogenesis and function (Griac et al., 1996; McGraw and Henry,
1989; Summers et al., 1988). While the cho2 opi3 double dele-
tion strain is auxotrophic for choline, it continues to grow for
some time after a shift to medium lacking choline, ﬁnally ceas-
ing growth when PC composition drops below 2% (Boumann et al.,
2006). During the process of PC depletion in this strain, both
PE and PI accumulate and considerable acyl chain remodeling of
PE occurs, leading to shortening and increased saturation of the
acyl chains, suggesting a regulatory mechanism that compensates
for the nonbilayer propensity of PE. However, Choi et al. (2004)
showed that the auxotrophic requirement of a cho2 (pem1)
opi3 (pem2) strain could also be satisﬁed in glucose grown cells
by propanolamine (Prn), which is incorporated into phospholipid
to form phosphatidylpropanolamine (PPrn). This leads to formation
of cellular membranes essentially devoid of methylated phospho-
lipids, with no compensatory shift in saturation of the acyl chains
of PE or PPrn. Since PPrn is a hexagonal phase forming phospholipid
like PE, these data suggest that the functions of PC, and methylated
phospholipids in general, are nonessential in glucose grown cells of
S. cerevisiae (Choi et al., 2004). However, expression and regulation
of INO1 and coregulated genes has not been examined in this strain
under these conditions.
As additional structural genes encoding the enzymes that cat-
alyze the reactions in phospholipid biosynthesis were identiﬁed
and characterized, it became possible to examine the effect on
regulation of INO1 and co-regulated genes of mutations in each
step along the CDP-DAG pathway leading to PC. However, the
identiﬁcation and cloning of the two genes in yeast encoding PS
decarboxylases proved especially challenging, as neither of the sin-
gle deletion mutants ultimately proved to have an auxotrophic
requirement for ethanolamine or choline and strains carrying
the single deletions retain considerable PS decarboxylase activ-
ity (Clancey et al., 1993; Trotter et al., 1993, 1995; Trotter and
Voelker, 1995). The PSD1 gene, encoding the mitochondrial form
of PS decarboxylase, was ultimately isolated in two different lab-
oratories virtually simultaneously each using somewhat different
strategies (Clancey et al., 1993; Trotter et al., 1993). The yeast psd1
strain was then used to isolate ethanolamine auxotrophs, thereby
identifying psd1 psd2 double mutants that retain virtually no PS
decarboxylase activity and thus, similar to cho1 mutants, require
ethanolamine or choline for growth (Trotter et al., 1995; Trotter
and Voelker, 1995). The ethanolamine auxotrophy of the psd1
psd2 strain enabled the cloning of the PSD2 gene and the creation of
a double deletion strain, psd1 psd2,  which retains no detectable
PS decarboxylase activity and is an ethanolamine/choline aux-
otroph (Trotter et al., 1995). In wild type strains, transcription
of PSD1 is regulated by inositol and ethanolamine, in a fashion
similar to the CHO1 gene, while transcription of the PSD2 gene
is not affected by any of these phospholipid precursors (Griac,
1997). The psd1 strain also fails to repress INO1 in the absence
of ethanolamine and exhibits INO1 overexpression in the absence
of both inositol and ethanolamine. However, the disruption of the
PSD2 gene has no effect on either INO1 or PSD1 expression and PSD2
itself is not regulated in response to inositol or ethanolamine (Griac,
1997).
3.3. Mutations in the structural genes encoding PI synthase and
CDP-DAG synthase also affect INO1 expression
A subsequent screen for mutants with Opi– phenotypes resulted
in the identiﬁcation of a mutant, initially named cdg1, which
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xhibited a very strong inositol excretion (Opi–) phenotype and
ery high constitutive INO1 expression, phenotypes that could not
e corrected by choline supplementation. The cdg1 mutant exhib-
ted changes in phospholipid synthesis consistent with a defect in
DP-DAG synthase, including very reduced synthesis of CDP-DAG
nd high PA levels (Klig et al., 1988a). This mutant was  later shown
y Shen et al. (1996) to carry a point mutation in the structural
ene for CDP-DAG synthase (CDS1), an essential gene. By modulat-
ng expression of the wild type CDS1 gene, Shen and Dowhan (1997)
howed that INO1 and CHO1 mRNA levels increased as expression of
DS1 decreased. These ﬁndings are consistent with the phenotype
f the original cdg1 point mutant (Klig et al., 1988a), as well as the
odel of regulation of these genes in response to PA accumulation,
s described above.
However, expression of the PIS1 gene, encoding phosphatidyl-
nositol (PI) synthase was found to be unaffected in strains with
odiﬁed CDS1 expression (Shen and Dowhan, 1997). The PIS1 gene
s regulated by carbon source (Anderson and Lopes, 1996) and
nder anaerobic conditions PIS1 is also regulated by Rox1p, which
s a repressor of hypoxic genes (Gardocki and Lopes, 2003). While
IS1 expression was originally believed to be completely uncou-
led from inositol/choline regulation (Anderson and Lopes, 1996;
ardocki and Lopes, 2003), Jani and Lopes (2008) later showed that
xpression of PIS1 is induced about twofold in response to inositol,
y a mechanism that is independent of the Ino2p and Ino4p tran-
cription factors. Regulation of PIS1 does, however, involve Ume6p,
 general regulator of INO1 and other phospholipid biosynthetic
enes (Jackson and Lopes, 1996), as discussed above. Indeed, both
me6p and Ino4p are positive regulators of PIS1 (Jani and Lopes,
008). The PIS1 gene is also regulated by zinc through the interac-
ion of the Zap1p transcription factor with the UASZRE element in
he PIS1 promoter under conditions of zinc depletion (Carman and
an, 2007; Han et al., 2005). The DPP1 gene encoding diacylglycerol
yrophosphatase is also among the genes induced by Zap1p under
inc depletion (Carman and Han, 2007; Han et al., 2001; Henry et al.,
012).
Importantly, the level of PIS1 expression affects expression
f UASINO containing genes. When PIS1 expression was placed
nder the control of the GAL1 promoter allowing PI synthesis
o be reduced, the INO1 and CHO1 genes were derepressed and
n Opi–phenotype was observed (Jani and Lopes, 2009). Thus, a
eduction in PI synthesis in response to reduced PIS1 expression
imics the reduction of PI synthesis that occurs in the absence
f exogenous inositol supplementation in wild type cells. Thus,
oth reduced expression of PIS1 and growth of wild type cells in
he absence of inositol lead to decreased PI synthesis and INO1
erepression (Jani and Lopes, 2009; Gaspar et al., 2006; Henry and
atton-Vogt, 1998; Loewen et al., 2004), but decreased PI synthe-
is itself is not the signal for activation of INO1. This is made clear
y the fact that mutants, such as cho2 and opi3, which are defec-
ive in synthesis of PC via the CDP-DAG pathway, have elevated
I levels, while expressing INO1 constitutively and exhibiting Opi–
henotypes (Henry and Patton-Vogt, 1998).
.4. PA provides the metabolic signal for derepression/repression
f UASINO containing genes in response to inositol
In each of the studies described above, in which derepression of
NO1 and/or an Opi– phenotype are observed, PA levels were either
irectly shown to have increased or could be predicted to have
ncreased on the basis of metabolic ﬂux (Henry and Patton-Vogt,
998). Indeed, PA metabolism is inﬂuenced by the rates of synthe-
is and turnover of essentially all lipids that are derived directly
r indirectly from it (Carman and Henry, 2007; Henry et al., 2012).
owever, none of the studies cited above speciﬁcally perturbed
A metabolism without having the consequence of also affectingics of Lipids 180 (2014) 23–43 31
the ﬂow and levels of intermediates from PA to PC along the CDP-
DAG pathway (Fig. 1), making it difﬁcult to determine the speciﬁc
metabolic signal involved. A breakthrough in “pin-pointing” PA as
the actual metabolic signal responsible for INO1 derepression came
as the result of discovery of both Opi– and choline excretion (Opc–)
phenotypes (Patton-Vogt et al., 1997) in strains carrying a temper-
ature sensitive mutation in the essential SEC14 gene, encoding the
yeast phosphatidylinositol transfer protein (PITP) (Bankaitis et al.,
1990, 2005).
The sec14ts mutant itself was isolated in the original screen
for temperature sensitive (Sec–) mutants, defective in secretion of
invertase, a periplasmic enzyme (Novick et al., 1980). The SEC14
gene was shown to encode an essential, cytoplasmic protein, which
functions to promote protein export from the Golgi (Bankaitis et al.,
1989). Sec14p was subsequently identiﬁed as a phosphatidylin-
ositol transfer protein (PITP) (Bankaitis et al., 1990), involved in
regulation of diverse cellular functions (Bankaitis et al., 2005).
The complex and diverse roles of Sec14p and related proteins in
yeast include coordination of PI and PC metabolism, regulation
of PC metabolism, phosphoinositide signaling and promotion of
Golgi secretory and vesicular transport from the Golgi and have
been extensively described in a number of comprehensive reviews
(Bankaitis et al., 2005; Ghosh and Bankaitis, 2011; Griac, 2007;
Howe and McMaster, 2006; LeBlanc and McMaster, 2010). Second
site mutations, referred to as “bypass suppressors”, that suppress
sec14 lethal growth defects were isolated and shown to include
the cki1, cct1 and pct1 mutations in the Kennedy pathway for PC
biosynthesis (Cleves et al., 1991). Skinner et al. (1995) subsequently
reported that Sec14p inﬂuences the activity of the Kennedy path-
way through inhibition of choline-phosphate cytidylyltransferase
(Pct1p) (Fig. 1), the rate-limiting enzyme in the pathway.
The sec14ts strains carrying Kennedy pathway bypass suppres-
sors exhibit high levels of PA and INO1 expression, coinciding
with elevated PC synthesis and turnover (Patton-Vogt et al., 1997;
Sreenivas et al., 1998). These observations provided the ﬁrst clear
evidence that increased accumulation of PA, rather than decreased
PC synthesis, is responsible for the signal for activation of INO1
expression (Sreenivas et al., 1998). The sec14tscki1, sec14tscct1
and sec14tspct1 strains all possess inositol excretion (Opi–) phen-
otypes and very strong choline excretion (Opc–) phenotypes when
growing at the sec14ts restrictive temperature of 37 ◦C (Patton-
Vogt et al., 1997). While wild type cells do not excrete detectable
choline in the Opc– assay, the cki1,  cct1 and pct1 mutants all
exhibit mild Opc– phenotypes, because they turn over PC via a phos-
pholipase D (Fig. 1) mediated route, liberating both free choline
and PA (Fig. 1). Yet, unlike wild type, mutants with defects in the
Kennedy pathway are unable to reincorporate choline produced
during PC turnover catalyzed by phospholipase D (Spo14/Pld1p)
back into PC and, thus, excrete it into the medium (Patton-Vogt
et al., 1997). However, sec14tscki,  sec14tscct and sec14tspct1
strains all exhibit enormously increased choline excretion rings at
the sec14ts restrictive temperature in comparison to strains carry-
ing only the respective Kennedy pathway mutations (Patton-Vogt
et al., 1997). Sreenivas et al. (1998) demonstrated that both the Opi–
and elevated Opc– phenotypes of sec14ts strains carrying bypass
suppressors in the Kennedy pathway are dependent on activation
of the phospholipase D encoded by the SPO14 (PLD1) gene. High
PC turnover catalyzed by phospholipase D produces both excess
choline, resulting in the Opc– phenotype, and high PA levels and
derepression of INO1, leading to the Opi– phenotype (Fig. 2). Dele-
tion of the SPO14 gene, encoding phospholipase D, simultaneously
eliminated the Opi– and the Opc– phenotypes in sec14 “bypass”
strains at a temperature semipermissive for sec14ts growth. High PA
levels produced by Spo14p (Pld1p) turnover of PC, in turn, proved
to be responsible for high INO1 expression and the Opi– phenotype
in these strains (Sreenivas et al., 1998). These phenotypes provided
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he pivotal clue that elevated PA, rather than decreased PC synthe-
is, generates the signal controlling derepression of INO1 and other
ASINO containing genes (Henry et al., 2012; Henry and Patton-
ogt, 1998; Sreenivas et al., 1998). Moreover, the activity of Spo14p
roved to be essential for bypass suppression of sec14ts growth
henotypes by all classes of bypass suppressors of sec14, not just
he suppressor mutations associated with the Kennedy pathway
Xie et al., 1998).
.5. Discovery of the mechanism of regulation of INO1 and other
ASINO genes in response to changing PA levels
The question then remained; how does the level of PA commu-
icate a signal to the transcription apparatus to control expression
f INO1 and coregulated genes? Loewen et al. (2004) provided an
nswer to this question, demonstrating that Opi1p is a PA binding
rotein, which interacts with PA in the perinuclear ER. In addi-
ion to PA binding domains, Opi1p also contains a motif, FFAT (two
henylalanines in an acidic tract), shown by Loewen et al. (2003)
o interact with an integral ER associated protein, Scs2p. Scs2p is a
omologue of mammalian VAP (VAMP associated protein) which
nteracts with a number of additional lipid associated proteins in
he ER. In the presence of exogenous inositol, PA remains at a low
evel as a consequence of being rapidly consumed as a precursor
n the synthesis of high levels of PI (Fig. 1). Conversely, when wild
ype cells are growing in the absence of inositol, PI levels are low
nd PA levels remain high (Gaspar et al., 2006, 2011). Since Opi1p
ethering to the ER requires interaction with both PA and Scs2p,
pi1p remains in the ER when cells are growing in the absence
f inositol (Loewen et al., 2004) (Fig. 3). However, when inositol
s abruptly added to the medium of cells acclimated to growth in
ts absence, PI synthesis increases dramatically, causing PA lev-
ls drop rapidly. The drop in PA results in loss of Opi1p binding
o the perinuclear ER and, consequently, it rapidly translocates to
he nucleus, where it represses INO1 and other Opi1p target genes
Loewen et al., 2004) (Fig. 3). Conversely, growth in the absence of
nositol results in increased build up of PA, resulting in retention of
pi1p in the perinuclear ER. This in turn results in derepression of
NO1 and coregulated UASINO containing genes (Jesch et al., 2005,
006; Loewen et al., 2004). Since the de novo synthesis of inositol
upported by Ino1p does not support a rate of PI synthesis compa-
able to that in cells provided with exogenous inositol, in wild type
ells growing in the absence of inositol, PI levels remain low and
A levels remain elevated (Gaspar et al., 2006, 2011).
. The critical roles of Pah1p and TAG metabolism in
egulation of glycerolipid homeostasis in yeast
Opi1p is not the only protein that recognizes PA in the ER.
ah1p, a homolog of mammalian lipin 1 (Pascual and Carman,
013), is a cytoplasmic Mg2+-dependent PA phosphatase that inter-
cts with PA in the perinuclear ER (Han et al., 2006, 2007). In
ice overexpression of lipin 1 causes obesity, while its loss causes
ipodystrophy (Peterfy et al., 2001; Phan and Reue, 2005). The fact
hat Pah1p shares sequence homology with lipin 1 at its N-terminal
nd within a HAD-like (haloacid dehydrogenase like) domain led
o the hypothesis that lipin 1 is also a PA phosphatase enzyme (Han
t al., 2006). Subsequent studies using puriﬁed human lipin 1 pro-
ein conﬁrmed that lipin 1 is indeed a PA phosphatase enzyme (Han
nd Carman, 2010). While interaction of Opi1p with PA plays a piv-
tal role in regulating the expression of phospholipid biosynthetic
enes (Henry et al., 2012; Loewen et al., 2004), Pah1p controls PA
omeostasis (Han et al., 2006). In addition to Pah1p, yeast contains
hree additional enzymes with PA phosphatase activity; Lpp1p,
pp1p, App1p (Chae et al., 2012; Faulkner et al., 1999; Toke et al.,ics of Lipids 180 (2014) 23–43
1998a,b; Wu et al., 1996). However, it is PA dephosphorylation by
Pah1p that generates the pool of DAG used in the synthesis of TAG
(Han et al., 2006), as well as the pool of DAG used in the synthesis of
PE and PC via the Kennedy pathway (Carman and Han, 2006, 2009)
(Fig. 1). Consequently, the pah1 mutant exhibits low TAG levels
and elevated levels of PA and PI (Han et al., 2006, 2007). The pah1
mutant also exhibits abnormal expansion of the nuclear membrane
(Santos-Rosa et al., 2005).
Consistent with its elevated PA levels in comparison to wild type
(Han et al., 2006), the pah1 mutant also exhibits elevated INO1
expression, both in the presence and absence of inositol (Han et al.,
2007). However, unlike opi1,  the pah1 mutant does not exhibit
an Opi– phenotype (Han et al., 2006) and INO1 is still subject to
repression in response to inositol in the pah1 strain, although
not to the same degree as in the wild type (Han et al., 2007).
Pah1p is found in both cytoplasmic and membrane fractions in
wild type yeast (Han et al., 2006). The association of Pah1p with
the membrane, where its substrate PA resides, is essential to its
function in vivo, and membrane association of Pah1p depends on
the phosphorylation state of the enzyme (Choi et al., 2011, 2012;
Karanasios et al., 2010; O’Hara et al., 2006). Dephosphorylation of
Pah1p by the Nem1p-Spo7p phosphatase complex (Santos-Rosa
et al., 2005) promotes both membrane anchoring of Pah1p via an
amino-terminal amphipathic helix and its activity as a PA phos-
phatase (Karanasios et al., 2010). A short carboxy-terminal acidic
peptide on Pah1p mediates its interaction with the Nem1p-Spo7p
phosphatase complex that is localized to the nuclear membrane
and ER. The Nem1p-Spo7p phosphatase complex is consequently
important for Pah1p membrane translocation and production of
DAG and TAG, as well as lipid droplet biogenesis (Karanasios et al.,
2013). The unconventional diacylglycerol kinase, Dgk1p, catalyzes
the formation of PA from DAG, utilizing CTP, instead of ATP, as
the phosphate donor in the reaction (Han et al., 2008a,b). Dgk1p
counteracts the function of Pah1p (Han et al., 2008a,b) but deletion
of the DGK1 gene does not itself result in major changes in lipid
metabolism or in INO1 expression in proliferating cells (Han et al.,
2008a).
5. TAG synthesis and breakdown are interdependent with
ongoing membrane lipid synthesis in actively growing cells
Because of its rapid and profound effects on the levels of both
PI and PA in actively growing cells, inositol availability inﬂuences
the levels and rates of synthesis and turnover of all lipids derived
directly or indirectly from PA and PI, including inositol phospho-
lipids and sphingolipids, DAG and TAG (Gaspar et al., 2006, 2008,
2011; Jesch et al., 2010). Accumulation of TAG, as cells enter into
stasis, as well as TAG turnover as cells exit stasis and reenter active
growth, has been extensively documented in yeast (Gray et al.,
2004; Kurat et al., 2006, 2009). However, changes in the availabil-
ity of inositol also lead to dramatic changes in the rates of turnover
and synthesis of TAG even during active growth (Gaspar et al., 2006,
2011).
5.1. The availability of inositol affects TAG accumulation and
turnover in logarithmically growing wild type cells
When exogenous inositol is supplied to actively growing yeast
cells that have been acclimated to growth in inositol free medium,
PI synthesis increases rapidly and dramatically, while TAG syn-
thesis declines (Gaspar et al., 2006, 2011). This is due to rapid
channeling of PA through CDP-DAG into PI synthesis leading to a
rapid decrease in PA levels (Loewen et al., 2004), making PA less
available as a precursor for TAG synthesis (Gaspar et al., 2006,
2011). Conversely, lack of inositol supplementation results in a
S.A. Henry et al. / Chemistry and Physics of Lipids 180 (2014) 23–43 33
Fig. 3. Model for the regulation of UASINO-containing genes by changing PA levels. In cells grown in the absence of inositol, PI levels are low due to the limited availability of
endogenously produced inositol, which leads to the accumulation of PA. Under these growth conditions, the Opi1p transcriptional repressor localizes to the cytoplasmic face
of  the ER though dual interactions with PA and Scs2p, and the transcription of UASINO-containing genes, regulated by the Ino2p–Ino4p complex, are maximally derepressed.
Upon the addition of inositol, PI synthesis dramatically increases, which causes the rapid consumption of the ER pool of PA. This drop in PA levels releases Opi1p, which
translocates to the nucleus, where it binds to Ino2p and represses the transcription of UASINO-containing genes, which is mediated by the general transcriptional repressor
Sin3p.
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ubstantial reduction in synthesis of PI and an increase in TAG
ynthesis (Gaspar et al., 2006; Kelley et al., 1988). When choline
s present in addition to inositol, PC synthesis also increases via
he Kennedy pathway, consuming DAG, the immediate precursor
o TAG (Fig. 1). Thus the presence of choline also acts in con-
ert with inositol to counteract the build up of TAG during active
rowth. Thus, even during logarithmic growth, a complex compe-
ition between TAG and phospholipid synthesis is ongoing (Gaspar
t al., 2011).
The cellular response to addition of inositol to wild type cells
reviously acclimated to growth in its absence includes a ﬁve- to
ix-fold increase in cellular PI content within a period of 30 min
Gaspar et al., 2006). This increase in PI content following addi-
ion of inositol is dependent upon fatty acids derived from multiple
ources, including de novo fatty acid synthesis, PC turnover and TAG
ydrolysis (Gaspar et al., 2006, 2011). The rapid increase in turnover
f PC that occurs following inositol addition requires participa-
ion of Nte1p (Gaspar et al., 2006), an ER-localized phospholipase B
Zaccheo et al., 2004). Nte1p was also shown to be responsible for
C turnover in yeast when choline is present in the medium and/or
hen cells are grown at 37 ◦C (Dowd et al., 2001).
As described above, TAG is also consumed in logarithmically
rowing wild type cells upon inositol reintroduction, coincident
ith the increase of PI content (Gaspar et al., 2011). Thus, upon shift
o inositol free medium, the storage lipids in lipid droplets are also
equired to maintain normal rates of phospholipid synthesis in pro-
iferating yeast cells (Gaspar et al., 2011). TAG degradation occurs
ia the activity of lipid hydrolases encoded by the TGL3, TGL4 and
GL5 genes (Athenstaedt and Daum, 2005; Kohlwein, 2010; Kurat
t al., 2009). At the cellular level, TAG degradation is upregulated
y Cdc28p/Cdk1p-dependent phosphorylation of the Tgl4p lipase
Kurat et al., 2009). Lipolysis contributes to bud formation, pre-
umably by providing precursors for synthesis of lipids involved
n membrane biogenesis or signaling (Kurat et al., 2009). The DAG
enerated from lipolysis is converted to PA by Dgk1p (Han et al.,
008a) and, consequently, dgk1 cells fail to resume growth from
tationary phase in the presence of the fatty acid synthesis inhibitor
erulenin (Fakas et al., 2011). However, when choline is present,
AG can be used directly for PC synthesis (Fig. 1), bypassing the
equirement of Dgk1p for growth resumption, thereby linking the
ennedy pathway for phospholipid synthesis to the mobilization
f TAG (Fakas et al., 2011).
.2. Cells unable to synthesize TAG exhibit an Ino– phenotype,
espite being able to derepress INO1
The synthesis of TAG is catalyzed mainly by the diacylglyc-
rol transferases encoded by the DGA1 and LRO1 genes (Oelkers
t al., 2000, 2002; Sorger and Daum, 2002), whereas the enzymes
ncoded by ARE1 and ARE2 primarily mediate the esteriﬁcation
f ergosterol and its precursors leading to steryl ester produc-
ion (Jensen-Pergakes et al., 2001; Sandager et al., 2000, 2002).
hese four enzymes, Dga1p, Lro1p, Are1p and Are2p, account for
AG and steryl ester biosynthesis in yeast. Synthesis of these
torage lipids begins during exponential growth and reaches
ts peak as cells enter stationary phase (Mullner and Daum,
004). The dga1lro1are1are2  quadruple mutant is an ino-
itol auxotroph (Ino– phenotype) at 37 ◦C, a phenotype that is
nhanced when choline is present (Gaspar et al., 2011). How-
ver, unlike many other strains exhibiting an Ino–phenotype,
he dga1lro1are1are2  strain does not display a defect in
NO1 derepression when shifted to inositol free medium (Gaspar
t al., 2011). However, upon reintroduction of inositol into such
nositol-deprived cultures, the dga1lro1are1are2  mutant
train exhibits slow recovery of PI content compared to wild type
ells. This is primarily due to the absence of TAG as a source of fattyics of Lipids 180 (2014) 23–43
acids, which in wild type cells serve as precursors for PI synthesis
upon recovery following inositol deprivation (Gaspar et al., 2011).
Moreover, synthesis of phospholipids, especially PI, is dramati-
cally reduced in the dga1lro1are1are2 strain even when it is
growing continuously in the presence of inositol. The mutant also
utilizes a greater proportion of newly synthesized PI than wild type
for the synthesis of inositol containing sphingolipids, especially in
the absence of inositol (Gaspar et al., 2011). Thus, storage lipid
synthesis actively inﬂuences membrane phospholipid metabolism
in logarithmically growing cells. Another indication of crosstalk
between membrane biogenesis versus lipid storage is the obser-
vation that following a block in membrane trafﬁcking, yeast cells
channel lipid metabolism from phospholipid synthesis into synthe-
sis of TAG and other neutral lipids to form lipid droplets (Gaspar
et al., 2008).
6. Inositol starvation in an ino1 mutant leads to rapid cell
death
As discussed above, S. cerevisiae,  mutants carrying loss-of-
function mutations in a large number of genes exhibit inositol
auxotrophy (Culbertson and Henry, 1975; Donahue and Henry,
1981b; Villa-Garcia et al., 2011; Young et al., 2010). Inositol
auxotrophs of Neurospora (Lester and Gross, 1959) and several
inositol-requiring species of yeast (Ridgway and Douglas, 1958)
were shown to die logarithmically when deprived of inositol, a
trait referred to by Ridgway and Douglas (1958) as “unbalanced
growth”. A similar phenomenon of rapid exponential loss of viabil-
ity was  observed in the ino1-13 mutant of S. cerevisiae,  defective in
IP synthase, when starved for inositol (Henry et al., 1977). A simi-
lar phenomenon was  also observed in fatty acid auxotrophs (fas1)
mutants, defective in fatty acid synthase, but not in ole1 mutants
defective in fatty acid desaturase, when starved for their respec-
tive fatty acid requirements (Henry, 1973; Henry and Horowitz,
1975). In the case of the ino1 and fas1 mutants, cell death could be
largely prevented by simultaneously interrupting protein synthe-
sis, either by starvation for an amino acid required by the strain in
question or by treating with cycloheximide. The fact that the phe-
nomenon of rapid cell death was observed in mutants defective in
both inositol and fatty acid biosynthesis starved for their respective
requirements, suggested that rapid and profound loss of viability
might be a general phenomenon in mutants defective in membrane
lipid biosynthesis (Henry et al., 1977). However, an ino1 cho1 strain,
auxotrophic both for inositol and for ethanolamine/choline, lost
viability at a rate comparable to the ino1 single mutant strain when
starved for inositol, but showed little viability loss when starved for
ethanolamine/choline, despite its abnormal membrane phospho-
lipid composition (Atkinson et al., 1980b). Thus, the rapid cell death
observed in the ino1 and fas1 mutants is not universally shared by
all mutants possessing defects in membrane lipid synthesis.
6.1. Inositol starvation in ino1 mutants leads to rapid cessation of
PI synthesis
In the original study of the ino1–13 mutant undergoing inosi-
tol starvation, cells continued to double for the ﬁrst 2 h and then
commenced to die logarithmically such that only 10% or less sur-
vived after 5 h. Under these circumstances, ino1–13 cells arrested
in all stages of budding, indicating that they did not undergo cell
cycle arrest (Henry et al., 1977). By 4 h of inositol starvation, PI
synthesis had virtually ceased, while synthesis of PS, PE and PC
continued at levels similar to the inositol supplemented control
(Henry et al., 1977). Becker and Lester (1977) examined the change
in lipid content during inositol starvation of both the ino1–13 strain
and a double mutant strain, ino1–13 ino4–8, and reported that PI
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evels dropped to virtually undetectable levels within 2 h following
 shift to inositol free medium. The drop in PI content was accom-
anied by a build up of PA and CDP-DAG. This early observation by
ecker and Lester (1977) of PA and CDP-DAG accumulation dur-
ng inositol deprivation in inositol auxotrophs foreshadowed later
xperiments, discussed above, which showed that wild type cells
rown in the absence of inositol also accumulate elevated levels
f both PA and CDP-DAG (Gaspar et al., 2006, 2011; Loewen et al.,
004). Hanson and Lester (Hanson and Lester, 1980) subsequently
eported that the rate of PI synthesis was drastically affected as
arly as 5–20 min  following removal of inositol and was  reduced
y more than 90% after 1–2 h of inositol starvation in the ino1–13
no4–8 strain. They also observed a decrease of 50% in the rate of
ynthesis of the inositol containing sphingolipids within 5–20 min
nd 75% by 1–2 h following removal of inositol in this strain.
he synthesis of di- and tri-phosphoinositides, while affected less
rastically than sphingolipid synthesis, also decreased measurably
ithin 1–2 h following removal of inositol, as did cell wall glycan
ynthesis. Thus, inositol starvation was shown to rapidly affect the
ate of synthesis of all inositol-containing lipids, as well as cell wall
lycan, in a mutant completely lacking Ino1p.
.2. Starvation of ino1, ino2 and ino4 mutants for inositol leads to
reater viability loss than starvation of other classes of auxotrophs
The question then arises; is “inositol-less death” in inositol aux-
trophs a unique phenomenon related to the vital functions of
nositol in metabolism and cellular function in yeast or is it trig-
ered by a generic mechanism(s) similar to those operating during
tarvation of other classes of auxotrophic mutants? It has been pos-
ulated that yeast and other free living organisms have necessarily
volved mechanisms for survival during starvation for “natural
utrients”, such as carbon, phosphorous, nitrogen and sulfur, which
ary in natural environments and which cells cannot manufacture
Boer et al., 2008). In contrast, mutants unable to synthesize an
ssential compound, such as leucine or uracil, which must be syn-
hesized endogenously from available “natural” nutrients, have not
ad the beneﬁt of natural selection to evolve protective mecha-
isms. Such mechanisms include concerted cell cycle arrest and
onservation of energy stores when cells are confronted with the
bsence of a nutrient. Consequently, under starvation for a com-
ound, such as leucine or uracil, for which auxotrophic cells lack
n evolved protective mechanism, such auxotrophs may  undergo
xponential loss of viability with a half-life of several days (Boer
t al., 2008).
Recent studies of starvation of methionine requiring mutants
f S. cerevisiae defective in methionine biosynthesis (met6 and
et13), suggest that these mutants react to methionine starva-
ion, as if starved for a natural nutrient such as phosphate, and
ndergo cell cycle arrest and consequently survive (Petti et al.,
011). In contrast, methionine auxotrophs having defects in the
ranscription factors Met31p or Met32p, which are involved in reg-
lation of a broad array of metabolic functions, were found by Petti
t al. (2011) to respond to methionine starvation by undergoing
ogarithmic cell death in a fashion more similar to the response of
eucine and uracil auxotrophs starved for their respective require-
ents (Boer et al., 2008). During inositol less death, however, cells
f ino1, ino2 or ino4 mutant strains lost 3–5 log orders of viabil-
ty within 24 h (Culbertson and Henry, 1975; Henry et al., 1975).
his rate of viability loss is signiﬁcantly more rapid and severe than
hat described for other classes of auxotrophs starved for their spe-
iﬁc requirements, including the methionine, leucine and uracil
uxotrophs (Boer et al., 2008; Petti et al., 2011) starved for their
peciﬁc requirements. Inositol starved ino1–13 cells lost 4–5 log
rders of viability within 24 h following inositol removal. Further-
ore, “inositol-less death” can be used to enrich and select forics of Lipids 180 (2014) 23–43 35
spontaneous mutants exhibiting auxotrophy for leucine, methio-
nine, tryptophan, lysine, histidine, uracil and adenine (Henry et al.,
1975).
6.3. Inositol starved ino1 mutants share some characteristics in
common with temperature sensitive Sec– mutants raised to their
restrictive temperature.
While effects of inositol starvation availability are more severe
than starvation for other types of auxotrophic requirements, simi-
larities do exist in certain of characteristics of inositol starved ino1
mutants and temperature sensitive secretion (Sec–) mutants raised
to their restrictive temperature. In both cases, metabolism con-
tinues while cell surface and membrane expansion ceases. When
ino1–13 cells were shifted to inositol free medium, they underwent
approximately one doubling in cell number and then arrested in all
stages of the cell cycle. However, after cell number stopped increas-
ing and both plasma membrane and cell wall ceased expanding,
the cells continued to metabolize (Henry et al., 1977). This ongo-
ing metabolism in cells no longer dividing or expanding in volume
resulted in an osmotic imbalance (Atkinson et al., 1977) and cell
density increased, causing the inositol starved cells to sediment
more rapidly in a ludox gradient than the inositol-supplemented
control cells (Henry et al., 1977). The sec1-1 mutant, the ﬁrst yeast
Sec– mutant to be isolated and characterized, was shown to be
blocked in cell surface growth as well as secretion (Novick and
Schekman, 1979). When a mixture sec1-1ts and wild type cells,
both of which had been shifted to the sec1-1ts restrictive tem-
perature for 3 h, was  applied to a ludox gradient similar to the
one used in the inositol starvation experiment described above,
the sec1-1 cells separated completely from wild type cells (Novick
et al., 1980). This procedure was then used to enrich (select) for
other classes of temperature sensitive Sec– mutants, leading to
the isolation of the mutants representing the 23 original com-
plementation groups of Sec–mutants isolated by Novick et al.
(1980).
Thus, by inference, all of the original Sec– mutants isolated in
the screen by Novick et al. (1980) share in common with inositol
starved ino1 cells, the property of cessation of membrane synthesis
and cell surface expansion, uncoupled from cessation of macro-
molecular synthesis. Moreover, Sec– strains shifted to restrictive
growth temperatures and inositol deprived wild type cells both
exhibit a build up of neutral lipids, especially TAG (Gaspar et al.,
2008, 2011). The sec13-1 mutant, isolated in the original screen by
Novick et al. (1980), was later shown to be defective in COPII vesicle
formation and secretory protein exit from the ER (Pryer et al., 1993;
Salama et al., 1993). This mutant also exhibits an Ino–phenotype
at a semi-permissive growth temperature (Gilstring et al., 1999)
and pronounced TAG accumulation when shifted to its restrictive
temperature (Gaspar et al., 2008). Moreover, the introduction of
mutations in the TAG synthase genes into the sec13-1 mutant back-
ground caused a reduction in the permissive growth temperature
at which the mutant could grow and resulted in the appearance
of the Ino– phenotype at still lower growth temperatures (Gaspar
et al., 2008). These ﬁndings suggest that secretory stress and inosi-
tol starvation both result in the channeling of lipid metabolism from
membrane phospholipid synthesis into TAG and do so in a syner-
gistic manner. Of the original Sec– mutants isolated by Novick et al.
(1980), only the sec13-1 (Gilstring et al., 1999) and sec14-1 mutants
(Kearns et al., 1997) have been reported to exhibit inositol auxotro-
phy at a semi-permissive growth temperature. However, a screen
of a genome-wide viable deletion collection for mutants exhibiting
inositol auxotrophy identiﬁed an additional 54 non-essential genes
encoding products involved in membrane trafﬁcking that confer
an Ino–phenotype (Villa-Garcia et al., 2011). These 54 mutants
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epresent about 13% of the total known nonessential genes that
xhibit the Ino– phenotype when mutated.
. Stress response signaling is triggered by changes in lipid
etabolism during inositol starvation
As described in previous sections, cells grown in the absence
f inositol contain PI levels that are 4–5 times lower than cells
rown in the presence of inositol, which leads to changes in the
etabolism lipids derived from PI, including phosphoinositides
Jesch et al., 2010), sphingolipids (Alvarez-Vasquez et al., 2005;
esch et al., 2010), as well as GPI anchors (Doering and Schekman,
996). These lipid metabolic changes are accompanied by the acti-
ation of several stress response signaling pathways, most notably
he UPR pathway (Cox et al., 1993; Cox and Walter, 1996; Kohno
t al., 1993; Mori et al., 1992, 1993; Nikawa and Yamashita, 1992),
s discussed above, and the cell integrity pathway controlled by the
ighly conserved protein kinase C-MAP kinase (PKC-MAPK) signal
ransduction pathway (Jesch et al., 2010; Nunez et al., 2008). More-
ver, deletion of components of these and other stress response
athways leads to an Ino– phenotype (Villa-Garcia et al., 2011),
ndicating that activation of these stress responses is required for
rowth in the absence of inositol and that growth of wild type
east in the absence of inositol is a stress inducing growth con-
ition. Indeed, an early indication that stress response signaling
s triggered by inositol starvation was the ﬁnding that mutants in
he UPR pathway are inositol auxotrophs (Cox et al., 1993; Nikawa
t al., 1996; Nikawa and Yamashita, 1992; Sidrauski et al., 1996). In
act, IRE1, the gene encoding the transmembrane kinase that senses
R stress (Cox and Walter, 1996; Mori et al., 2000) was originally
dentiﬁed in a screen for inositol auxotrophs, and its name—Inositol
Equiring—indicates this fact (Nikawa and Yamashita, 1992). Ini-
ially it was believed that the UPR pathway regulates the expression
f INO1 and other UASINO-regulated genes (Cox et al., 1997),
uggesting that the UPR directly controls the transcription of
hospholipid biosynthetic gene expression. However, it has been
emonstrated that neither INO1 nor UASINO-containing genes, in
eneral, are directly controlled by the UPR (Chang et al., 2002; Jesch
t al., 2006).
.1. Inositol deprivation triggers the UPR in wild type cells
The UPR is thought to maintain ER homeostasis by balanc-
ng protein folding in the luminal ER with secretory capacity
Gardner et al., 2013; Korennykh and Walter, 2012; Walter and Ron,
011). In yeast, activation of the UPR is solely controlled by Ire1p,
hich senses ER stress produced by inositol starvation, secretory
tress, or accumulation of unfolded ER luminal proteins (Walter
nd Ron, 2011). Current models for UPR activation in yeast sug-
est that Ire1p, a highly conserved transmembrane ER resident
rotein containing both luminal and cytosolic domains, directly
inds to unfolded proteins in the lumen of the ER, which induces
ts oligomerization and activation (Credle et al., 2005). Activated
re1p subsequently catalyzes the unconventional splicing of HAC1
RNA, leading to translation of the Hac1p transcription factor and
p-regulation of UPR target genes, including ER resident protein-
olding chaperones and oxidoreductases (Travers et al., 2000),
hich together function to maintain ER homeostasis (Walter and
on, 2011). Moreover, ire1 and hac1 mutants both exhibit ino-
itol auxotrophy (Cox et al., 1993; Nikawa et al., 1996; Nikawa and
amashita, 1992).
Despite a wealth of studies investigating the mechanism of UPR
ctivation, it remains unclear how inositol deprivation triggers ER
tress. Paradoxically, although inositol starvation is a potent acti-
ator of the UPR (Chang et al., 2002; Cox et al., 1997; Jesch et al.,ics of Lipids 180 (2014) 23–43
2006; Pincus et al., 2010), unfolded proteins do not appear to
build up in the ER of cells starved for inositol. In a recent study
using a pelleting assay to measure unfolded protein aggregates in
the ER lumen, Promlek et al. (2011) did not detect accumulated
unfolded proteins in inositol-depleted cells, suggesting that inosi-
tol depletion leads to membrane lipid aberrations that are sensed
by Ire1p in the absence of unfolded proteins. This proposal is sup-
ported by the observation of Promlek et al. (2011) that ire1 mutant
cells, lacking a critical unfolded protein interaction domain in the
luminal domain of Ire1p, exhibited identical activation kinetics dur-
ing inositol starvation compared to wild type cells deprived of
inositol. Notably, UPR activation by treatment of these same ire1
mutants with DTT or tunicamycin, both of which induce the accu-
mulation of unfolded proteins in the ER, was signiﬁcantly reduced
(Promlek et al., 2011). These results suggest that the cytoplasmic
or transmembrane domain of Ire1p senses membrane aberrancy,
a conclusion which is in agreement with recent experiments in
mammalian cells showing that accumulation of saturated fatty
acids triggers UPR (Volmer et al., 2013). Therefore, inositol star-
vation may trigger the UPR by producing ER stress that is caused by
membrane- or lipid-related changes in the ER and is distinct from
a build up of unfolded proteins.
One possible source of ER stress produced by inositol starva-
tion may  be through its effects on sphingolipid metabolism. As
described above, inositol induces changes in the synthesis and
levels of numerous lipids, including the sphingolipids (Alvarez-
Vasquez et al., 2005; Jesch et al., 2010). Moreover, several recent
studies indicate that sphingolipid metabolism may regulate ER
membrane homeostasis. Mutant cells lacking ORM1 and ORM2,
which are members of the conserved ORMDL family of ER mem-
brane proteins that negatively regulate sphingolipid metabolism
(Breslow et al., 2010; Han et al., 2010), exhibit a constitutive UPR
(Han et al., 2010). Mutant orm1 orm2 cells contain elevated
levels of sphingolipids (Breslow et al., 2010; Han et al., 2010)
and are hypersensitive to stress, including inositol starvation (Han
et al., 2010). Similarly, isc1 mutant cells, which contain ele-
vated sphingolipids due to a block in sphingolipid turnover (Sawai
et al., 2000), also exhibit constitutive UPR (Gururaj et al., 2013).
Conversely, inhibiting sphingolipid synthesis with myriocin sup-
presses the activation of the UPR by inositol starvation, but not
by DTT treatment (Promlek et al., 2011). These results suggest the
intriguing possibility that elevated sphingolipids in the ER lead
to membrane perturbations that activate the UPR independent of
unfolded protein accumulation. However, much additional work
will be required to substantiate this hypothesis.
Another possible source of ER stress produced by inositol star-
vation may  be through its effects on membrane trafﬁcking. Similar
to inositol deprivation in wild type cells, secretory stress caused by
slowing or blocking membrane trafﬁcking at multiple steps in the
secretory pathway in various Sec– mutants also leads to activation
of the UPR (Chang et al., 2002, 2004; Jonikas et al., 2009). How-
ever, membrane trafﬁcking does not appear to be affected in wild
type cells deprived of inositol, since wild type cells, unlike cells of
Ino– mutants, continue to grow indeﬁnitely in the absence of ino-
sitol. Moreover, Doering and Schekman (1996) demonstrated that
the rates of trafﬁcking of prototypical secretory proteins in yeast
including invertase, alkaline phosphatase, and carboxypeptidase Y,
were largely unaffected by inositol starvation of an ino1–13 ino2–8
strain.
However, the studies of Doering and Schekman (1996) revealed
that trafﬁcking of Gas1p, a glycosyl phosphatidylinositol (GPI)-
anchored protein, was inhibited between the ER to the plasma
membrane (PM) in inositol starved ino1–13 ino2–8 cells. Moreover,
the block in Gas1p ER-to-PM trafﬁcking under these conditions was
shown to be due to cessation of synthesis the GPI anchor (Doering
and Schekman, 1996), for which PI serves as a precursor. The
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athway of GPI anchor synthesis is highly conserved between yeast
nd mammals (Pittet and Conzelmann, 2007) with an estimated 60
PI-anchored proteins in yeast (Fujita and Kinoshita, 2012). The
PI anchor is synthesized from PI in the ER, where newly syn-
hesized proteins are added to the fully constructed GPI anchor en
loc. It is only after proteins are added to the GPI anchor that these
roteins are able to exit the ER through packaging into COPII vesi-
les. Gas1p trafﬁcking was shown to be inhibited by at least 90%
ithin 95 min  and was essentially completely blocked by 135 min
ollowing removal of inositol from the medium of ino1–13 ino2–8
ells. Nevertheless, under these conditions, trafﬁcking of Gas1p was
ompletely reversible upon addition of inositol even after 180 min
Doering and Schekman, 1996). Like Sec– mutants raised to their
estrictive temperature, mutants that are defective in the synthe-
is of GPI anchors also exhibit induction of the UPR (Castillon et al.,
011; Jonikas et al., 2009). Thus, activation the UPR in wild type cells
eprived of exogenous inositol may  result from general slowing in
PI anchor synthesis caused by the reduced rate of PI synthesis that
ccurs in wild type cells relying on de novo synthesis of inositol
Gaspar et al., 2006; Loewen et al., 2004).
.2. Genome wide studies have revealed many more genes
egulated by inositol
Genome wide expression studies of cells grown in the presence
nd absence of inositol and/or choline have expanded the number
f genes identiﬁed as being regulated by inositol, with or without
holine (Jesch et al., 2005, 2006; Nunez et al., 2008; Santiago and
amoun, 2003). One initial study (Jesch et al., 2005), which com-
ared the changes in gene expression in cells grown continuously in
he presence of inositol versus those grown in its absence, revealed
 surprisingly small number of genes, which are differentially regu-
ated under these two steady state growth conditions. Indeed, only
9 genes, including both UASINO-containing genes and UPR targets,
ere found to be signiﬁcantly upregulated in cells grown contin-
ously in the absence of inositol, versus in its presence and only 3
enes were observed to be signiﬁcantly upregulated in the presence
f inositol (Jesch et al., 2005). While, the inclusion of choline in the
edia increased the number of genes observed to be differentially
xpressed in presence versus the absence of inositol, choline, on its
wn, had little effect on global gene expression in the absence of
nositol (Jesch et al., 2005).
Gene expression proﬁling following the addition of inositol to
ells acclimated to growth in the absence of inositol identiﬁed addi-
ional signaling pathways that respond rapidly to the changes in
ipid metabolism induced by inositol addition (Gaspar et al., 2006;
oewen et al., 2004). As described in previous sections, addition of
nositol leads to a rapid and profound change in PI metabolism as
ell as other changes in phospholipid and TAG metabolism. In all
ver 700 genes showed a change in expression over a 30 min  time
ourse following inositol addition (Jesch et al., 2006). Six distinct
xpression responses were detected by this analysis, suggesting
hat multiple ER-to-nucleus signaling pathways are regulated by
hanges in lipid metabolism that are induced by inositol addition.
.3. PKC-MAPK signaling is activated transiently during inositol
tarvation of wild type cells
The UPR was the only stress response pathway observed to be
ctivated in cells acclimated to “steady state” growth in the absence
f inositol (Jesch et al., 2005). However, subsequent studies have
evealed that, while the PKC-MAPK pathway is not activated in cells
rown continuously in the absence of inositol (Jesch et al., 2005,
006), it is activated in actively dividing cells shifted to inositol free
edium for a period of 3 h (Jesch et al., 2010; Nunez et al., 2008).
hese data suggest that some stress response signaling is onlyics of Lipids 180 (2014) 23–43 37
transiently activated following depletion of exogenous inositol
from the growth medium of wild type cells. Wild type cells, unlike
ino1, ino2 and ino4 mutants are able to depress INO1, thus enabling
the de novo synthesis of inositol. However, under these conditions,
as described above, wild type cells still exhibit a somewhat reduced
growth rate, slowing of PI synthesis and many other changes in
lipid metabolism and composition. Indeed, recent gene expres-
sion proﬁling conducted using logarithmically growing wild type
cells, shifted from medium containing inositol to medium lack-
ing inositol, has revealed that numerous additional stress response
pathways are transiently activated in wild type cells as they adjust
to growth in the absence of inositol (Jesch and Henry, unpublished).
Moreover, the genome-wide screen for inositol auxotrophy study
conducted by Villa-Garcia et al. (2011), revealed Ino– phenotypes
associated with mutants defective in many of these same stress
response pathways. Besides the UPR and PKC-MAPK pathways dis-
cussed above, pathways found to be activated following an abrupt
shift of actively growing wild type cells to inositol free medium
include the high osmolarity glycerol (HOG)/p38 and calcineurin
pathways (Jesch and Henry, unpublished). Interestingly, Ino– phen-
otypes in mutants defective in UPR and PKC-MAPK pathways are
alleviated by overexpression of the NTE1 gene (Fernandez-Murray
et al., 2009; Nunez et al., 2008), encoding a phospholipase B, which
controls PC turnover in response to high temperature and the pres-
ence of choline (Fernandez-Murray and McMaster, 2005; Zaccheo
et al., 2004). Moreover, mutants lacking the MAPK of the PKC path-
way, Slt2p, show severe defects in lipid metabolism, including
aberrant turnover of phosphatidylcholine as well as accumulation
of PC, DAG, TAG, and free sterols, suggesting that PKC-MAPK plays
a crucial role in control of lipid homeostasis (Nunez et al., 2008).
While the precise mechanism for activation of the UPR pathway
during inositol starvation remains elusive, a clue for the activation
of PKC-MAPK signaling during inositol starvation of wild type cells
came from the ﬁnding that inhibition of the synthesis of inositol
sphingolipid synthesis by pharmacological agents, such as myriocin
or aureobasidin A, leads to robust activation of PKC-MAPK signaling.
Several studies have shown that inositol sphingolipid synthesis is
sensitive to inositol supplementation. As discussed above, inositol
sphingolipid synthesis was  shown to be inhibited during inositol
starvation both in the ino1–13 ino4–8 mutant (Hanson and Lester,
1980) and in wild type strains (Jesch et al., 2010). Conversely,
synthesis of inositol sphingolipids increases upon provision of
inositol to wild type cells adapted to continuous growth in its
absence (Alvarez-Vasquez et al., 2005). Hanson and Lester (1980)
also showed that inositol starvation of an ino1–13 ino4–8 mutant
strain led to a decrease in the rate of synthesis of phosphoinosi-
tides. However, the relative levels of all four phosphoinositides
were observed to increase and a biosensor, which detects PI4P, was
seen to accumulate on the plasma membrane during inositol star-
vation of wild type cells starved for inositol (Jesch et al., 2010).
The accumulation of the PI4P biosensor on the plasma membrane
correlated with PKC-MAPK activation, suggesting that sphingolipid
levels may control access of PI4P effector proteins required for PKC-
MAPK activation on the plasma membrane (Jesch et al., 2010). This
model is consistent with the ﬁnding that Stt4p-dependent forma-
tion of PI4P is necessary for PKC-MAPK activation (Audhya and
Emr, 2002). The activation the PKC-MAPK signaling pathway dur-
ing inositol starvation leads to the up-regulation of genes involved
in cell wall organization and biogenesis controlled by the Rlm1p
transcription factor (Nunez et al., 2008), which may  relieve plasma
membrane stress when inositol sphingolipid synthesis is reduced.
In addition, the triggering of PKC-MAPK signaling by inositol star-
vation, or by interrupting inositol sphingolipid synthesis, results
in increased Sir2p-dependent telomeric silencing (Lee et al., 2013),
presumably through phosphorylation of Sir3p, a known target of
Slt2p (Ai et al., 2002; Ray et al., 2003) and component of the highly
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onserved Sir complex (Hecht et al., 1996; Strahl-Bolsinger et al.,
997). Thus, inositol sphingolipid metabolism controls multiple
ownstream stress responses.
. Conclusions and reﬂections
The yeast, S. cerevisiae,  has proven to be a powerful model
ystem in which to dissect the biochemical pathways and regula-
ory mechanisms controlling lipid metabolism and lipid mediated
ignaling pathways that are broadly applicable to eukaryotic
rganisms. The studies described in this review, involving the
ork of dozens of laboratories over a span of more than four
ecades; a period during which the genetic, biochemical, molec-
lar methodologies available in yeast underwent an enormous
volution. Many of the gene enzyme relationships in yeast lipid
etabolism, described in this review, led to discoveries of the func-
ions of related homologous genes and proteins in other eukaryotic
rganisms, including humans, including INO1, encoding inositol 3-
hosphate synthase and CDS1, CDP-diacylglycerol synthase. The
iscovery that human LIPIN is an enzyme with PA-phosphatase
ctivity came from the discovery that it is a homolog of the yeast
ene Pah1p gene. Many other examples of the insights derived
rom yeast that have proven pivotal to progress in biomedical
esearch in the broadest sense could be cited. However, the pri-
ary focus of this review is the enormous progress derived from
he application of genetics, biochemical and molecular technolo-
ies, applied to the dissection of regulatory mechanisms governing
ipid biosynthesis, metabolism and signaling in yeast. Most impor-
antly, the approach of tracing the genetics of the biosynthesis and
etabolism of inositol, a molecule essential to eukaryotic signaling
nd lipid metabolism, has enabled the discovery of intricate regula-
ory mechanisms that control both phospholipid biosynthesis and
ipid mediated signaling. Looking to the future, many questions
emain to be answered. For example, understanding the mech-
nism of activation and attenuation of stress response signaling
y lipid metabolism as well as the interconnectedness of these
athways remain areas of great importance that are as yet poorly
nderstood. Yeast will continue to be an important model system
n which to probe these questions, using its powerful molecular
enetics to build on insights discussed in this review.
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